117 related articles for article (PubMed ID: 38044180)
1. Retraction notice to "Risk factors for hip fracture among elderly patients with Alzheimer's disease" [Journal of the Neurological Sciences 223 (2004), 107-112].
Sato Y; Kanoko T; Satoh K; Iwamoto J
J Neurol Sci; 2024 Jan; 456():122823. PubMed ID: 38044180
[No Abstract] [Full Text] [Related]
2. Retraction notice to "Risk factors for hip fracture among elderly patients with Parkinson's disease" [Journal of the Neurological Sciences 182 (2001), 89-93].
Sato Y; Kaji M; Tsuru T; Oizumi K
J Neurol Sci; 2024 Jan; 456():122821. PubMed ID: 38087765
[No Abstract] [Full Text] [Related]
3. Retraction notice to "Influence of immobilization on bone mass and bone metabolism in hemiplegic elderly patients with a long-standing stroke" [Journal of the Neurological Sciences 156 (1998), 205-210].
Sato Y; Fujimatsu Y; Kikuyama M; Kaji M; Oizumic K
J Neurol Sci; 2024 Jan; 456():122824. PubMed ID: 38087764
[No Abstract] [Full Text] [Related]
4. Retraction notice to "Efficacy of Bisphosphonates against Hip Fracture in Elderly Patients with Stroke and Parkinson Diseases: Meta-analysis of Randomized Controlled Trials" [Journal of Stroke and Cerebrovascular Diseases, Vol. 23, No. 10 (November-December), 2014: pp 2714-2724].
Zhang W; Zhu C; Sun M; Ge Y; Yan G
J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105682. PubMed ID: 33685623
[No Abstract] [Full Text] [Related]
5. The relation between hip fracture and alzheimer's disease in the canadian national population health survey health institutions data, 1994-1995. A cross-sectional study.
Weller I
Ann Epidemiol; 2000 Oct; 10(7):461. PubMed ID: 11018377
[TBL] [Abstract][Full Text] [Related]
6. Retraction notice to "Coagulation-fibrinolysis abnormalities in patients receiving antiparkinsonian agents" [Journal of the Neurological Sciences 212 (2003), 55-58].
Sato Y; Kaji M; Metoki N; Yoshida H; Satoh K
J Neurol Sci; 2024 Jan; 456():122818. PubMed ID: 38087762
[No Abstract] [Full Text] [Related]
7. Retraction notice to "Amelioration by mecobalamin of subclinical carpal tunnel syndrome involving unaffected limbs in stroke patients" [Journal of the Neurological Sciences 231 (2005), 13-18].
Sato Y; Honda Y; Iwamoto J; Kanoko T; Satoh K
J Neurol Sci; 2024 Jan; 456():122819. PubMed ID: 38087761
[No Abstract] [Full Text] [Related]
8. Retraction notice to "Influence of immobilization upon calcium metabolism in the week following hemiplegic stroke" [Journal of the Neurological Sciences 175 (2000), 135-139].
Sato Y; Kuno H; Kaji M; Etoh K; Oizumi K
J Neurol Sci; 2024 Jan; 456():122822. PubMed ID: 38072682
[No Abstract] [Full Text] [Related]
9. Retraction notice to "Hyperhomocysteinemia in Japanese patients with convalescent stage ischemic stroke: Effect of combined therapy with folic acid and mecobalamine" [Journal of the Neurological Sciences 202 (2002), 65-68].
Sato Y; Kaji M; Kondo I; Yoshida H; Satoh K; Metoki N
J Neurol Sci; 2024 Jan; 456():122820. PubMed ID: 38087763
[No Abstract] [Full Text] [Related]
10. Risk factors for hip fracture among elderly patients with Alzheimer's disease.
Sato Y; Kanoko T; Satoh K; Iwamoto J
J Neurol Sci; 2004 Aug; 223(2):107-12. PubMed ID: 15337610
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials.
Iwamoto J; Matsumoto H; Takeda T
Curr Med Res Opin; 2008 May; 24(5):1379-84. PubMed ID: 18384711
[TBL] [Abstract][Full Text] [Related]
12. Hip fractures and Alzheimer's disease in elderly institutionalized Canadians.
Weller I; Schatzker J
Ann Epidemiol; 2004 May; 14(5):319-24. PubMed ID: 15177270
[TBL] [Abstract][Full Text] [Related]
13. Retraction notice to "High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease" Bone Volume 23, Issue 6, December 1998, Pages 555-557.
Sato Y; Asoh T; Oizumi K
Bone; 2019 Aug; 125():210. PubMed ID: 31103716
[No Abstract] [Full Text] [Related]
14. Notice of Retraction: Sato Y, et al. The Prevention of Hip Fracture With Risedronate and Ergocalciferol Plus Calcium Supplementation in Elderly Women With Alzheimer Disease: A Randomized Controlled Trial. Arch Intern Med. 2005;165(15):1737-1742.
Bauchner H; Redberg RF
JAMA Intern Med; 2016 Sep; 176(9):1256. PubMed ID: 27258431
[No Abstract] [Full Text] [Related]
15. Retraction Notice to "MicroRNA-16-5p/BTG2 axis affects neurological function, autophagy and apoptosis of hippocampal neurons in Alzheimer's disease" [Brain Res. Bull. 175 (2021) 254-62].
Dong LX; Bao HL; Zhang YY; Liu Y; Zhang GW; An FM
Brain Res Bull; 2022 Oct; 189():4. PubMed ID: 35994984
[No Abstract] [Full Text] [Related]
16. Development and validation of a predictive nomogram for subsequent contralateral hip fracture in elderly patients within 2 years after hip fracture surgery.
Liang J; Zhang J; Lou Z; Tang X
Front Med (Lausanne); 2023; 10():1263930. PubMed ID: 38179269
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease and risk of hip fracture: a meta-analysis study.
Zhao Y; Shen L; Ji HF
ScientificWorldJournal; 2012; 2012():872173. PubMed ID: 22629218
[TBL] [Abstract][Full Text] [Related]
18. Association of insulin resistance with delirium and CSF biomarkers of Alzheimer's disease in elderly patients with hip fracture.
Wang J; Shuang P; Li Z; Zhao L; Wang X; Liu P
Aging Clin Exp Res; 2023 Jul; 35(7):1521-1529. PubMed ID: 37166562
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease.
Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
J Clin Psychiatry; 2017 Mar; 78(3):e257-e263. PubMed ID: 28146612
[TBL] [Abstract][Full Text] [Related]
20. Survival analysis of patients with hip fracture, Shiraz, Iran.
Maharlouei N; Jafarzadeh F; Rezaianzadeh A; Janfada M; Mesbahi A; Namazi H; Lankarani KB
Arch Osteoporos; 2020 Mar; 15(1):33. PubMed ID: 32124051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
